Cardiology Today -- Results of the MADIT-II trial showed that patients who received an implantable cardioverter defibrillator had a 45% mortality probability compared with a 61% risk among patients who did not receive the device.
Cardiology Today -- Results of the MADIT-II trial showed that patients who received an implantable cardioverter defibrillator had a 45% mortality probability compared with a 61% risk among patients who did not receive the device.